Carnie, Christopher J. http://orcid.org/0000-0001-7006-5596
Acampora, Aleida C.
Bader, Aldo S. http://orcid.org/0000-0001-5760-5113
Erdenebat, Chimeg
Zhao, Shubo
Bitensky, Elnatan
van den Heuvel, Diana
Parnas, Avital
Gupta, Vipul
D’Alessandro, Giuseppina http://orcid.org/0000-0001-5448-8652
Sczaniecka-Clift, Matylda
Weickert, Pedro
Aygenli, Fatih
Götz, Maximilian J.
Cordes, Jacqueline
Esain-Garcia, Isabel
Melidis, Larry http://orcid.org/0000-0001-6853-2722
Wondergem, Annelotte P.
Lam, Simon http://orcid.org/0000-0002-4476-0971
Robles, Maria S.
Balasubramanian, Shankar
Adar, Sheera
Luijsterburg, Martijn S. http://orcid.org/0000-0001-5796-6541
Jackson, Stephen P. http://orcid.org/0000-0001-9317-7937
Stingele, Julian http://orcid.org/0000-0001-6020-2075
Article History
Received: 13 April 2023
Accepted: 29 February 2024
First Online: 10 April 2024
Competing interests
: S.B. is a founder and shareholder of Biomodal Ltd., Inflex Ltd. and RNAvate Ltd. L.M. is a consultant for Inflex Ltd. S.P.J works part time as Chief Research Officer at Insmed Innovation UK Ltd. S.P.J is a founding partner of Ahren Innovation Capital LLP and is co-founder, a board member and Chair of the Scientific Advisory Board of Mission Therapeutics Ltd. S.P.J. is a consultant and shareholder of Inflex Ltd. The authors declare no other competing interests.